Qiuhong Li
16Patents
4h-index
6Co-inventors
49Inventor score
Filing activity: May 26, 2010 → Jun 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD777332S1 | Absorbent pad | General | 5 | Active |
| US11053291B2 | Delivery of Nrf2 as therapy for protection against reactive oxygen species | Chemistry; Metallurgy | 5 | Active |
| US10981961B2 | Delivery of card protein as therapy for occular inflammation | Chemistry; Metallurgy | 4 | Active |
| US10314893B2 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders | Emerging Cross-Sectional Technologies | 4 | Active |
| US11512326B2 | Small angiotensin peptide expression system in mammalian cells | Chemistry; Metallurgy | 2 | Active |
| US9248057B2 | Method of applying bulk glue for nursing pad base film to four corners of sanitary product nursing pad base film and device therefor | Emerging Cross-Sectional Technologies | 1 | Active |
| US11179281B2 | Multilayer-structure absorbent core for nursing pad, and method for preparing absorbent core | Emerging Cross-Sectional Technologies | 1 | Active |
| US11739130B2 | Delivery of card protein as therapy for ocular inflammation | Chemistry; Metallurgy | 1 | Active |
| US10182948B2 | Method and device for making absorbent cores used in disposable hygiene pad | Emerging Cross-Sectional Technologies | 1 | Active |
| US11945853B2 | Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides | Chemistry; Metallurgy | 0 | Active |
| US12060395B2 | Delivery of NRF2 as therapy for protection against reactive oxygen species | Chemistry; Metallurgy | 0 | Active |
| US11241487B2 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US12213551B2 | Manufacturing process and apparatus for duckbill mask | Human Necessities | 0 | Active |
| US12415841B2 | Delivery of card protein as therapy for occular inflammation | Chemistry; Metallurgy | 0 | Active |
| US11377479B2 | Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides | Chemistry; Metallurgy | 0 | Active |
| US12059454B2 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.